Nystatin A3

Nystatin A3 is a lipid of Polyketides (PK) class. Nystatin a3 is associated with abnormalities such as Mycoses, Candidiasis of the genitals and Gigantism. The involved functions are known as Drug Interactions, Process, Synthesis, Fermentation and Anabolism. Nystatin a3 often locates in Cell membrane, Membrane, Protoplasm, Entire oral cavity and integral to membrane. The associated genes with Nystatin A3 are Gene Clusters. The related lipids are Sterols, 1,2-oleoylphosphatidylcholine, Membrane Lipids, DOPE and N-caproylsphingosine.

Cross Reference

Introduction

To understand associated biological information of Nystatin A3, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Nystatin A3?

Nystatin A3 is suspected in Mycoses, Candidiasis of the genitals, Gigantism and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Nystatin A3

PubChem Associated disorders and diseases

What pathways are associated with Nystatin A3

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Nystatin A3?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Nystatin A3?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Nystatin A3?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Nystatin A3?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Nystatin A3?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Nystatin A3

Download all related citations
Per page 10 20 50 100 | Total 1594
Authors Title Published Journal PubMed Link
Volkmer E et al. Successful nystatin powder treatment of posttraumatic invasive Aspergillus fumigatus wound infection refractory to systemic antifungal therapy. 2009 J Trauma pmid:18815576
Savino JA et al. Routine prophylactic antifungal agents (clotrimazole, ketoconazole, and nystatin) in nontransplant/nonburned critically ill surgical and trauma patients. 1994 J Trauma pmid:8295245
Kondo C et al. Predictive genomic biomarkers for drug-induced nephrotoxicity in mice. 2012 J Toxicol Sci pmid:22863853
Al-Dwairi ZN et al. The effect of antifungal agents on surface properties of poly(methyl methacrylate) and its relation to adherence of Candida albicans. 2012 J Prosthodont Res pmid:22841909
Urban VM et al. Effect of the association of nystatin with a tissue conditioner on its ultimate tensile strength. 2006 Sep-Oct J Prosthodont pmid:16958730
Neppelenbroek KH et al. Effect of Incorporation of Antifungal Agents on the Ultimate Tensile Strength of Temporary Soft Denture Liners. 2018 J Prosthodont pmid:29135059
Urban VM et al. Superficial distribution and identification of antifungal/antimicrobial agents on a modified tissue conditioner by SEM-EDS microanalysis: a preliminary study. 2009 J Prosthodont pmid:19515168
Urban VM et al. Effect of the addition of antimicrobial agents on Shore A hardness and roughness of soft lining materials. 2015 J Prosthodont pmid:25082183
Ritchie GM et al. The etiology, exfoliative cytology, and treatment of denture stomatitis. 1969 J Prosthet Dent pmid:5256067
Pigno MA et al. The efficacy of antifungal agents incorporated into a facial prosthetic silicone elastomer. 1994 J Prosthet Dent pmid:8164173
Johnson GH et al. Clinical evaluation of a nystatin pastille for treatment of denture-related oral candidiasis. 1989 J Prosthet Dent pmid:2657027
Douglas WH and Clarke DA Physical and mechanical properties of nystatin-containing denture liners. 1975 J Prosthet Dent pmid:1100810
Holst E Natamycin and nystatin for treatment of oral candidiasis during and after radiotherapy. 1984 J Prosthet Dent pmid:6607989
Truhlar MR et al. Use of a new assay technique for quantification of antifungal activity of nystatin incorporated in denture liners. 1994 J Prosthet Dent pmid:8006850
Deshpande SD et al. Characterization and antibiotic sensitivity patterns of yeast-like organisms. 1986 J Postgrad Med pmid:3528467
Schulz JC et al. Unfolding and folding internal friction of β-hairpins is smaller than that of α-helices. 2015 J Phys Chem B pmid:25741584
Ghielmetti G et al. Relationship between acute toxicity in mice and polymorphic forms of polyene antibiotics. 1976 J Pharm Sci pmid:778376
Croy SR and Kwon GS Polysorbate 80 and Cremophor EL micelles deaggregate and solubilize nystatin at the core-corona interface. 2005 J Pharm Sci pmid:16200548
Llabot JM et al. Novel mucoadhesive extended release tablets for treatment of oral candidosis: "in vivo" evaluation of the biopharmaceutical performance. 2009 J Pharm Sci pmid:18803261
Hombach J et al. Development and in vitro evaluation of a mucoadhesive vaginal delivery system for nystatin. 2009 J Pharm Sci pmid:18563796
Fairbrother JE et al. Evaluation of nystatin stability using tristimulus colorimetry. 1980 J Pharm Sci pmid:7205586
CHANG JC et al. Colorimetric assay of nystatin. 1963 J Pharm Sci pmid:14020052
Fernández Campos F et al. Development and characterization of a novel nystatin-loaded nanoemulsion for the buccal treatment of candidosis: ultrastructural effects and release studies. 2012 J Pharm Sci pmid:22777575
Marín-Quintero D et al. Formulation design and optimization for the improvement of nystatin-loaded lipid intravenous emulsion. 2013 J Pharm Sci pmid:23970386
Wayland LG and Weiss PJ Identification of antibiotics in sensitivity disks. 1968 J Pharm Sci pmid:4173079
Tsuji K and Robertson JH Analysis of tetracycline in pharmaceutical preparations by improved high-performance liquid chromatographic method. 1976 J Pharm Sci pmid:1263088
Ng AW et al. Development of liposomal polyene antibiotics: an historical perspective. 2003 Jan-Apr J Pharm Pharm Sci pmid:12753730
Groeschke J et al. Stability of amphotericin B and nystatin in antifungal mouthrinses containing sodium hydrogen carbonate. 2006 J Pharm Biomed Anal pmid:16740372
Pendela M et al. Simultaneous determination of lidocaine hydrochloride, hydrocortisone and nystatin in a pharmaceutical preparation by RP-LC. 2011 J Pharm Biomed Anal pmid:21794999
Llabot JM et al. HPLC method for the determination of nystatin in saliva for application in clinical studies. 2007 J Pharm Biomed Anal pmid:17658236
Baratieri SC et al. Multivariate analysis of nystatin and metronidazole in a semi-solid matrix by means of diffuse reflectance NIR spectroscopy and PLS regression. 2006 J Pharm Biomed Anal pmid:16102931
Ali SA et al. Leishmanicidal activity of Nystatin (mycostatin): a potent polyene compound. 1997 J Pak Med Assoc pmid:9529849
Gallagher R Methadone mouthwash for the management of oral ulcer pain. 2004 J Pain Symptom Manage pmid:15120763
Usta Y Persistent hiccups: an unusual presentation and treatment. 2012 J Pain Symptom Manage pmid:22248794
Blyth CC et al. Chemoprophylaxis of neonatal fungal infections in very low birthweight infants: efficacy and safety of fluconazole and nystatin. 2012 J Paediatr Child Health pmid:22970680
Atai Z et al. In vivo study of antifungal effects of low-molecular-weight chitosan against Candida albicans. 2017 J Oral Sci pmid:28904319
Kaomongkolgit R et al. Antifungal activity of alpha-mangostin against Candida albicans. 2009 J Oral Sci pmid:19776506
Scardina GA et al. Chronic hyperplastic candidosis: a pilot study of the efficacy of 0.18% isotretinoin. 2009 J Oral Sci pmid:19776507
Geerts GA et al. Effect of an antifungal denture liner on the saliva yeast count in patients with denture stomatitis: a pilot study. 2008 J Oral Rehabil pmid:18793352
Quinn DM The effectiveness, in vitro, of miconazole and ketoconazole combined with tissue conditioners in inhibiting the growth of Candida albicans. 1985 J Oral Rehabil pmid:3886866
Pinelli LA et al. Ricinus communis treatment of denture stomatitis in institutionalised elderly. 2013 J Oral Rehabil pmid:23438045
Thomas CJ and Nutt GM The in vitro fungicidal properties of Visco-gel, alone and combined with nystatin and amphotericin B. 1978 J Oral Rehabil pmid:361931
Chan A and Ignoffo RJ Survey of topical oral solutions for the treatment of chemo-induced oral mucositis. 2005 J Oncol Pharm Pract pmid:16595065
Kim HJ et al. Antifungal Effect of a Dental Tissue Conditioner Containing Nystatin-Loaded Alginate Microparticles. 2018 J Nanosci Nanotechnol pmid:29448504
Bulacio L et al. Oral infections caused by yeasts in patients with head and neck cancer undergoing radiotherapy. Identification of the yeasts and evaluation of their antifungal susceptibility. 2012 J Mycol Med pmid:23518170
El-Wahidi M et al. [Bio-guided isolation of an antifungal from Haliclona enamela collected from Jorf Lasfar port, Morocco]. 2013 J Mycol Med pmid:23726234
Semis R et al. Evaluation of antifungal combinations of nystatin-intralipid against Aspergillus terreus using checkerboard and disk diffusion methods. 2015 J Mycol Med pmid:25639922
Mansourian A et al. The comparative study of antifungal activity of Syzygium aromaticum, Punica granatum and nystatin on Candida albicans; an in vitro study. 2014 J Mycol Med pmid:25442923
Choukri F et al. In vitro susceptibility profile of 200 recent clinical isolates of Candida spp. to topical antifungal treatments of vulvovaginal candidiasis, the imidazoles and nystatin agents. 2014 J Mycol Med pmid:25442913
Padilha MM et al. Anti-inflammatory activity of aqueous and alkaline extracts from mushrooms (Agaricus blazei Murill). 2009 J Med Food pmid:19459738